European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN
Language English Country Great Britain, England Media print-electronic
Document type News, Research Support, Non-U.S. Gov't
PubMed
34139485
PubMed Central
PMC8219752
DOI
10.1016/j.esmoop.2021.100174
PII: S2059-7029(21)00134-4
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Neoplasms * therapy MeSH
- Delivery of Health Care MeSH
- Rare Diseases MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- News MeSH
Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Medical Oncology Amsterdam UMC University of Amsterdam Amsterdam The Netherlands
Department of Medical Oncology Charing Cross Hospital Campus of Imperial College London London UK
Department of Medical Oncology University Medical Centre Groningen Groningen The Netherlands
Institute of Biomedicine of Sevilla Virgen Virgen del Rocío University Hospital Seville Spain
International Neuroendocrine Cancer Alliance Boston USA
Lithuanian University of Health Sciences Department of Neurosurgery Kaunas Lithuania
Maria Skłodowska Curie Institute Warsaw Poland
Medical Oncology Department Institut Curie Paris France
Medical University of Graz Graz Austria
Melanoma Patient Network Europe OcuMel Birmingham UK
National Institute of Oncology Budapest Hungary
Neuroendocrine Cancer Unit Royal Free Hospital London UK
Oncology Department and Danish Centre for Particle Therapy University Hospital Aarhus Denmark
Oncology Department Centro Hospitalar e Universitário Universitário do Porto Porto Portugal
Research and Innovation Department Centre Léon Bérard Lyon France
See more in PubMed
Gatta G., Capocaccia R., Botta L. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet – a population-based study. Lancet Oncol. 2017;18(8):1022–1039. PubMed
de Pinieux G., Karanian M., Le Loarer F. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One. 2021;16(2):e0246958. PubMed PMC
Gatta G., van der Zwan J.M., Casali P.G. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47:2493–2511. PubMed
Gatta G., Ciccolallo L., Kunkler I. Survival from rare cancer in adults: a population-based study. Lancet Oncol. 2006;7:132–140. PubMed
Heudel P.E., Cousin P., Lurkin A. Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhone-Alpes region. Int J Clin Oncol. 2014;19:744–752. PubMed
Fayet Y., Coindre J.M., Dalban C. Geographical accessibility of the referral networks in France. intermediate results from the IGeAS research program. Int J Environ Res Public Health. 2018;15:2204. PubMed PMC
Martin-Broto J., Hindi N., Cruz J. Relevance of reference centers in sarcoma care and quality item evaluation: results from the prospective registry of the Spanish Group for Research in Sarcoma (GEIS) Oncologist. 2019;24:e338–e346. PubMed PMC
Blay J.Y., Honore C., Stoeckle E. Surgery in reference centres improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019;30:1143–1153. PubMed PMC
Blay J.Y., Soibinet P., Penel N. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28:2852–2859. PubMed PMC
Bonvalot S., Gaignard E., Stoeckle E. Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a Nationwide Study of the French Sarcoma Group from the NetSarc Database. Ann Surg Oncol. 2019;26:2286–2293. PubMed
Casali P.G., Abecassis N., Aro H.T. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(suppl 4):iv268–iv269. PubMed
Casali P.G., Abecassis N., Aro H.T. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(suppl 4):iv267. PubMed
Casali P.G., Bielack S., Abecassis N. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(suppl 4):iv79–iv95. PubMed
Franceschi E., Hofer S., Brandes A.A. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol. 2019;20:e715–e728. PubMed
Nicholson A.G., Sauter J.L., Nowak A.K. EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. J Thorac Oncol. 2020;15:29–49. PubMed
Kusamura S., Kepenekian V., Villeneuve L. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2020;47:36–59. PubMed
https://ec.europa.eu/health/sites/health/files/ern/docs/integration_healthcaresystems_en.pdf Available at. Accessed June 7, 2021.
https://ec.europa.eu/health/sites/default/files/ern/docs/integration_healthcaresystems_en.pdf Available at. Accessed June 7, 2021.
https://www.esmo.org/oncology-news/2020-cancer-incidence-and-mortality-in-eu-27-countries Available at. Accessed June 7, 2021.
http://download2.eurordis.org.s3.amazonaws.com/ern/Draft%20Recommendations%20for%20Integration_final.pdf Available at. Accessed June 7, 2021.
Tumiene B., Graessner H., Mathijssen I.M. European Reference Networks: challenges and opportunities. J Community Genet. 2021;17:1–13. PubMed PMC
